Literature DB >> 6743508

5-fluorouracil metabolism monitored in vivo by 19F NMR.

A N Stevens, P G Morris, R A Iles, P W Sheldon, J R Griffiths.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6743508      PMCID： PMC1976923          DOI： 10.1038/bjc.1984.146

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

Review 1.  An update on the biochemistry of 5-fluorouracil.

Authors:  B Ardalan; R Glazer
Journal:  Cancer Treat Rev       Date:  1981-09       Impact factor: 12.111

Review 2.  Studies of analogs of fluorinated pyrimidine in Japan.

Authors:  Y Sakurai
Journal:  Recent Results Cancer Res       Date:  1981

3.  Methods for the complete analysis of 5-fluorouracil metabolites in cell extracts.

Authors:  A L Pogolotti; P A Nolan; D V Santi
Journal:  Anal Biochem       Date:  1981-10       Impact factor: 3.365

4.  Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU)RNA.

Authors:  S Spiegelman; R Nayak; R Sawyer; R Stolfi; D Martin
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

5.  Chemotherapy for colorectal cancer with a combination of PALA and 5-FU.

Authors:  A Y Bedikian; J R Stroehlein; D A Karlin; R W Bennetts; G P Bodey; M Valdivieso
Journal:  Cancer Treat Rep       Date:  1981 Sep-Oct

6.  Effect of 5-fluorouracil on the synthesis and translation of polyadenylic acid-containing RNA from regenerating rat liver.

Authors:  C K Carrico; R I Glazer
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

7.  Methotrexate-induced misincorporation of uracil into DNA.

Authors:  M Goulian; B Bleile; B Y Tseng
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

8.  In vivo carbon-13 nuclear magnetic resonance studies of mammals.

Authors:  J R Alger; L O Sillerud; K L Behar; R J Gillies; R G Shulman; R E Gordon; D Shae; P E Hanley
Journal:  Science       Date:  1981-11-06       Impact factor: 47.728

9.  Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a Phase I trial.

Authors:  J M Kirkwood; W Ensminger; A Rosowsky; N Papathanasopoulos; E Frei
Journal:  Cancer Res       Date:  1980-01       Impact factor: 12.701

10.  Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas.

Authors:  J L Au; Y M Rustum; E J Ledesma; A Mittelman; P J Creaven
Journal:  Cancer Res       Date:  1982-07       Impact factor: 12.701
View more
  35 in total

1.  [Magnetic resonance imaging spectroscopy. Part 1: Basics].

Authors:  P Bachert; L Schröder
Journal:  Radiologe       Date:  2003-12       Impact factor: 0.635

Review 2.  Noninvasive methods to study drug distribution.

Authors:  Ruediger E Port; Walter Wolf
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

Review 3.  NMR studies of drug metabolism and disposition.

Authors:  J D Bell; D G Gadian; N E Preece
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 4.  The unique potential for noninvasive imaging in modernizing drug development and in transforming therapeutics: PET/MRI/MRS.

Authors:  Walter Wolf
Journal:  Pharm Res       Date:  2010-10-01       Impact factor: 4.200

Review 5.  Uses and limitations of nuclear magnetic resonance (NMR) spectroscopy in clinical pharmacokinetics.

Authors:  M C Malet-Martino; R Martino
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

6.  Enhanced uptake of ifosfamide into GH3 prolactinomas with hypercapnic hyperoxic gases monitored in vivo by (31)P MRS.

Authors:  Loreta M Rodrigues; Simon P Robinson; Paul M J McSheehy; Marion Stubbs; John R Griffiths
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

7.  Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and dose.

Authors:  G W Visser; G C Gorree; G J Peters; J D Herscheid
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Non-invasive molecular and functional imaging of cytosine deaminase and uracil phosphoribosyltransferase fused with red fluorescence protein.

Authors:  Ligang Xing; Xuelong Deng; Khushali Kotedia; Ellen Ackerstaff; Vladimir Ponomarev; C Clifton Ling; Jason A Koutcher; Gloria C Li
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

Review 9.  In vivo 19F nuclear magnetic resonance spectroscopy: a potential monitor of 5-fluorouracil pharmacokinetics and metabolism.

Authors:  J L Evelhoch
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

10.  A 19F nuclear magnetic resonance study of uptake and metabolism of 5-fluorocytosine in susceptible and resistant strains of Candida albicans.

Authors:  M Di Vito; F Podo; A Torosantucci; G Carpinelli; W L Whelan; D Kerridge; A Cassone
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.